Impact of Government Regulation on Prescription Drug Marketing and Promotion
INTRODUCTION The Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) are the two governing U.S. regulatory agencies that affect the marketing and promotion of health-care industry products. The FDA primarily impacts the marketing and promotion practices of the prescription pharmaceutical, biological, medical device, and animal drug industries. The FTC primarily affects nonprescription/ over-the-counter (OTC) pharmaceuticals, nutritional and cosmetic marketing, and promotional practices. A following chapter in this book will discuss the current responsibilities of the FTC and the health-care industries it regulates. Although, recent legislation not currently in effect, the Non-Prescription Drug Modernization Act (November 2007) has been proposed to allow FDA to regulate OTC drug advertising, this chapter will discuss the relationship of the FDA and the health-care industries it currently regulates, with a focus on prescription drug marketing and promotion.